--- title: Cell and Gene Therapy | Azenta description: Bring cell and gene therapy projects to market with speed and precision using Azenta's best-in-class solutions deployed across every phase of development. image: https://web.azenta.com/hubfs/2022%20Cell%20and%20Gene%20Therapy%20Campaign/Content%20Assets/CGT%20Email%203/Azenta_CGT_US_EM-Hero-Lrg_Transcend_Expectations.png --- [![Azenta Life Sciences](https://web.azenta.com/hubfs/Azenta%20Logo%20and%20Brand%20Assets/Azenta%20Logos/Azenta_Logo_Hubspot_FullColor.svg "Azenta Life Sciences")](https://www.azenta.com) Open main menu Close main menu [HOME](https://web.azenta.com/cell-and-gene-therapy) [DISCOVERY](https://web.azenta.com/cell-and-gene-therapy/discovery?hsLang=en) [PRECLINICAL & CLINICAL](https://web.azenta.com/cell-and-gene-therapy/clinical?hsLang=en) [MANUFACTURING & DISTRIBUTION](https://web.azenta.com/cell-and-gene-therapy/manufacturing?hsLang=en) [CONTACT AN EXPERT](https://web.azenta.com/cell-and-gene-therapy-contact-an-expert?hsLang=en) ![](https://web.azenta.com/hs-fs/hubfs/2022%20Cell%20and%20Gene%20Therapy%20Campaign/Overview%20Landing%20Page/00_StickyNav/push%20up.png?width=50&name=push%20up.png) # CELL AND GENE THERAPY ## Research and Discovery Solutions   It’s now possible to bring cell and gene therapies to market with speed and precision. Azenta Life Sciences provides best-in-class services, solutions, and technology across every phase of development. [![CONTACT US](https://no-cache.hubspot.com/cta/default/3478602/318264af-2945-46d7-96fd-f0a32bd8dd65.png)](https://cta-redirect.hubspot.com/cta/redirect/3478602/318264af-2945-46d7-96fd-f0a32bd8dd65) ![...](https://web.azenta.com/hubfs/2022%20Cell%20and%20Gene%20Therapy%20Campaign/Overview%20Landing%20Page/01_Hero/Azenta_Overview_Hero_Image_1618_Carousel1.jpg) ## Preclinical & clinical phase Azenta Life Sciences offers a global network of biorepositories and laboratories for end-to-end sample collection, storage, and management, as well as automated cryogenic storage solutions. [![CONTACT US](https://no-cache.hubspot.com/cta/default/3478602/bff7899a-6e6a-4a6b-860b-6f8f954e1e36.png)](https://cta-redirect.hubspot.com/cta/redirect/3478602/bff7899a-6e6a-4a6b-860b-6f8f954e1e36) ![...](https://web.azenta.com/hubfs/2022%20Cell%20and%20Gene%20Therapy%20Campaign/Overview%20Landing%20Page/01_Hero/Azenta_Overview_Hero_Image_Carousel2.jpg) ## Manufacturing & Distribution Phase Rely on Azenta Life Sciences for critical reagent and product management solutions, including flexible pharmaceutical cold chain logistics, to meet cGMP and regulatory requirements. [![CONTACT US](https://no-cache.hubspot.com/cta/default/3478602/bff7899a-6e6a-4a6b-860b-6f8f954e1e36.png)](https://cta-redirect.hubspot.com/cta/redirect/3478602/bff7899a-6e6a-4a6b-860b-6f8f954e1e36) ![...](https://web.azenta.com/hubfs/2022%20Cell%20and%20Gene%20Therapy%20Campaign/Overview%20Landing%20Page/01_Hero/Azenta_Overview_Hero_Image_Carousel3.jpg) ## Preclinical & clinical phase It’s now possible to bring cell and gene therapies to market with speed and precision. Azenta Life Sciences provides best-in-class services, solutions, and technology across every phase of development. [![CONTACT US](https://no-cache.hubspot.com/cta/default/3478602/bff7899a-6e6a-4a6b-860b-6f8f954e1e36.png)](https://cta-redirect.hubspot.com/cta/redirect/3478602/bff7899a-6e6a-4a6b-860b-6f8f954e1e36) ![...](https://web.azenta.com/hubfs/2022%20Cell%20and%20Gene%20Therapy%20Campaign/Overview%20Landing%20Page/01_Hero/Azenta_Overview_Hero_Image_Carousel4.jpg) 1 2 3 4 ## CELL AND GENE THERAPY CHALLENGES ## Products and services for *complex cell and gene therapy environments* Throughout the cell and gene therapy development cycle, there are common challenges that arise. The right partner can help clear the path for your breakthrough cell and gene therapies. ![Azenta_Overview_IncreasingChallenges_Image](https://web.azenta.com/hubfs/Azenta_Overview_IncreasingChallenges_Image.png "Azenta_Overview_IncreasingChallenges_Image") --- ![Chart - Overview](https://web.azenta.com/hs-fs/hubfs/Chart%20-%20Overview.png?width=50&height=46&name=Chart%20-%20Overview.png "Chart - Overview") SCALING UP Rigor and reproducibility are essential as therapies advance toward approval. --- ![Question - Overview](https://web.azenta.com/hs-fs/hubfs/Question%20-%20Overview.png?width=50&height=47&name=Question%20-%20Overview.png "Question - Overview") PROTOCOL AMBIGUITY Inadequately defined protocols for emerging and existing therapies can lead to roadblocks. --- ![Sample Management - Overview](https://web.azenta.com/hs-fs/hubfs/Sample%20Management%20-%20Overview.png?width=50&height=46&name=Sample%20Management%20-%20Overview.png "Sample Management - Overview") SAMPLE MANAGEMENT Cold Chain logistics and storage challenges complicate clinical trials and manufacturing. ## CAPABILITIES VIDEO ## Your CGT vision is now ## within reach [![azenta life sciences cell and gene therapy video](https://no-cache.hubspot.com/cta/default/3478602/28af2f14-50e0-479f-afaa-d7f9dce173ab.png)](https://cta-redirect.hubspot.com/cta/redirect/3478602/28af2f14-50e0-479f-afaa-d7f9dce173ab) ## ELEVATE YOUR SCIENCE ## *Transcend* expectations See how Azenta Life Sciences can help you address challenges proactively to mitigate risk and accelerate development. [![download infographic](https://web.azenta.com/hs-fs/hubfs/2022%20Cell%20and%20Gene%20Therapy%20Campaign/Overview%20Landing%20Page/04_Elevate%20Your%20Science/download%20infographic.png?width=210&height=36&name=download%20infographic.png "download infographic")](https://web.azenta.com/hubfs/2022%20Cell%20and%20Gene%20Therapy%20Campaign/Overview%20Landing%20Page/74001-INFO%200424%20Cell%20%26%20Gene%20Therapy%20Infographic.pdf?hsLang=en) --- ![Azenta_Overview_Elevate_04](https://web.azenta.com/hubfs/Azenta_Overview_Elevate_04.svg "Azenta_Overview_Elevate_04") GLOBAL STORAGE LOCATIONS & LOGISTICS NETWORK From cell banks to cGMP materials and finished products, our trained staff and certified facilities specialize in cold chain storage and management and provide a fully documented audit trail. --- ![Azenta_Overview_Elevate_01](https://web.azenta.com/hubfs/2022%20Cell%20and%20Gene%20Therapy%20Campaign/Overview%20Landing%20Page/04_Elevate%20Your%20Science/Azenta_Overview_Elevate_01.svg "Azenta_Overview_Elevate_01") AUTOMATED STORAGE SOLUTIONS Solutions and expertise including cryogenic, supporting detailed inventory tracking, and reporting capabilities. --- ![Azenta_Overview_Elevate_02-1](https://web.azenta.com/hubfs/2022%20Cell%20and%20Gene%20Therapy%20Campaign/Overview%20Landing%20Page/04_Elevate%20Your%20Science/Azenta_Overview_Elevate_02-1.svg "Azenta_Overview_Elevate_02-1") PROPRIETARY GENOMICS PROTOCOLS Customers rely on our proprietary hairpin and GC-rich protocols to synthesize and sequence long and difficult DNA sequences with trusted results.   --- ![Azenta_Overview_Elevate_03](https://web.azenta.com/hubfs/Azenta_Overview_Elevate_03.svg "Azenta_Overview_Elevate_03") INDUSTRY EXPERTS We will guide you through common challenges of advanced therapy development. ## COMPREHENSIVE SOLUTIONS ## *Preparing* for scalable ## CGT solutions Azenta Life Sciences provides a comprehensive range of solutions across every phase of CGT development. We'll support the rigor of your program all the way from target discovery through scale-out. ### [  Discovery TARGET DISCOVERY | LEAD GENERATION & CHARACTERIZATION](https://web.azenta.com/cell-and-gene-therapy/discovery?hsLang=en) ### [  Preclinical & Clinic VECTOR & CELL BANK CONFIRMATION | CLINICAL TRIALS](https://web.azenta.com/cell-and-gene-therapy/clinical?hsLang=en) ### [  Manufacturing & Distribution MANUFACTURING SCALE-UP | THERAPEUTICS MANAGEMENT](https://web.azenta.com/cell-and-gene-therapy/manufacturing?hsLang=en) Next-Generation Sequencing Next-Generation Sequencing   Synthetic DNA Solutions     Sanger Sequencing Sanger Sequencing Sanger Sequencing Automated Storage and Cold Chain Product Automated Storage and Cold Chain Product Automated Storage and Cold Chain Product Sample and Material Storage Solutions Sample and Material Storage Solutions Sample and Material Storage Solutions Digital PCR (dPCR) Digital PCR (dPCR)   ## PATIENT IMPACT ## How the Whitehead family continues the fight against childhood cancers In 2010, Emily Whitehead was diagnosed with lymphoblastic leukemia. Just five-years old, she received chemotherapy - the best available treatment at the time. When her cancer returned in 2011, Emily became the first child in the world to receive an experimental CAR T-cell therapy. [READ MORE](https://www.azenta.com/blog/whitehead-family-continues-fight-against-childhood-cancers) ## MONTHLY WEBINAR ## *Join Us* for Bridging the Gap ### A monthly panel discussion on emerging topics that are changing the field of cell and gene therapy  Co-sponsored by the Emily Whitehead Foundation with prominent guests and hosts from hospitals, treatment centers, and the cell and gene therapy industry. [READ MORE](https://web.azenta.com/cgtwebinar?hsLang=en) ## STAY IN TOUCH ## Be among the first to learn *what's newly possible* Want to validate, optimize, or scale up right now? Need to know what's next? Connect with Azenta Life Sciences, leading the way in CGT infrastructure and expertise. ![Azenta_Logo_Primary_FullColor_BlackType_RGB_JP](https://web.azenta.com/hs-fs/hubfs/ja-jp/JP_images/Azenta_Logo_Primary_FullColor_BlackType_RGB_JP.png?width=200&height=66&name=Azenta_Logo_Primary_FullColor_BlackType_RGB_JP.png "Azenta_Logo_Primary_FullColor_BlackType_RGB_JP") - - - - Copyright © 2022 Azenta US, Inc.    [Privacy Policy](https://www.azenta.com/privacy-statement)   |   [Cookie Policy](https://www.azenta.com/cookie-policy)   |   [Terms and Conditions](https://www.azenta.com/terms-and-conditions)   |    [Terms of Use](https://www.azenta.com/terms-and-conditions)    |     [Careers](https://careers.azenta.com/)